| Conservative management of second-trimester cervical ectopic pregnancy with placenta percreta. | |
| | |
MedLine Citation:
|
PMID: 17140571 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To report successful conservative management of advanced cervical ectopic pregnancy with placenta percreta. DESIGN: Case report. Setting: University tertiary care hospital. PATIENT(S): A 37-year-old woman with second-trimester cervical ectopic pregnancy and placenta percreta. INTERVENTION(S): Ultrasound-guided injection of potassium chloride into the fetal heart followed by multiple systemic methotrexate injections, removal of fetal bones, cervical cerclage suture, and Foley catheter placement for control of hemorrhage. MAIN OUTCOME MEASURE(S): Low maternal morbidity and successful conservative management with preservation of fertility. RESULT(S): The cervical ectopic pregnancy was treated successfully without significant morbidity; the uterus was preserved, and the woman was delivered of a full-term live fetus in the next pregnancy. CONCLUSION(S): Advanced cervical ectopic pregnancy with placenta percreta is associated with high morbidity with surgical intervention. Conservative management with attendant low morbidity and uterus preservation is possible in advanced cervical ectopic pregnancy. |
| | |
Authors:
|
Usha Verma; Furio Maggiorotto |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2006-11-29 |
Journal Detail:
|
Title: Fertility and sterility Volume: 87 ISSN: 1556-5653 ISO Abbreviation: Fertil. Steril. Publication Date: 2007 Mar |
Date Detail:
|
Created Date: 2007-03-16 Completed Date: 2007-03-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372772 Medline TA: Fertil Steril Country: United States |
Other Details:
|
Languages: eng Pagination: 697.e13-6 Citation Subset: IM |
Affiliation:
|
Miller School of Medicine, University of Miami, Miami, Florida 33136, USA. uverma@med.miami.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abortifacient Agents, Nonsteroidal
/
administration & dosage Abortion, Therapeutic Adult Cerclage, Cervical Cervix Uteri Female Humans Methotrexate / therapeutic use Placenta Accreta / therapy* Potassium Chloride / administration & dosage Pregnancy Pregnancy, Ectopic / therapy*, ultrasonography |
| Chemical | |
Reg. No./Substance:
|
0/Abortifacient Agents, Nonsteroidal; 59-05-2/Methotrexate; 7447-40-7/Potassium Chloride |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Molecular analysis of the neuropeptide Y1 receptor gene in human idiopathic gonadotropin-dependent p...
Next Document: The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagoni...